DOWNLOAD THIS WHITE PAPER AS A PDF BY CLICKING ON THIS LINK The abuse and misuse of prescription opioid products is a serious and growing public health problem. Opioid products are often manipulated to bypass extended-release (ER) properties. As such, the FDA is encouraging the development of opioid formulations that are more difficult to abuse Read more
May is speed month here in Indiana, home of the Indy 500. Improved Pharma is celebrating speed month by highlighting services that help you speed your drug development and reduce time to market. Importantly, it is Improved Pharma’s expertise and scientific knowledge that is the key to faster, cheaper drug development. We have a range Read more
Improved Pharma LLC will be exhibiting in booth 551, conveniently located in the center of the Formulation and Quality section next to one of the Poster Forums. We look forward to meeting with you to discuss the latest advances in pharmaceutical research and development. Have a problem with solubility or bioavailability? Want to reformulate your Read more
Award honorees have made significant contributions to pharmaceutical sciences that promote public health ARLINGTON, VA (SEPTEMBER 21, 2018) The American Association of Pharmaceutical Scientists (AAPS) is proud to announce the winners of four of its global leadership awards: Pharmaceutical Global Health, Emerging Leader, AAPS Foundation Graduate Fellowships, and Student Chapter of the Year. Recognizing leaders Read more
Improved Pharma, LLC is also proud to announce a collaboration with Excelsus Structural Solutions (ESS, Switzerland) to provide services related to Synchrotron X-ray diffraction for both amorphous and crystalline materials. The combination of Prof. Byrn's expertise in structural characterization of amorphous pharmaceuticals via total scattering, spectroscopic and thermal techniques, with recent advances by ESS Read more
Professor Simon Billinge of Columbia University and Improved Pharma have established a collaboration agreement to provide Synchrotron services to the pharmaceutical industry and pharmaceutical developers in a seamless manner. This collaboration will greatly simplify business linkages to Professor Billinge’s program. In many cases Improved Pharma will collect data at Professor Billinge’s direction and he will Read more
Dr. Pamela A. (Martoglio) Smith has joined Improved Pharma as COO. Dr. Smith was most recently Vice President of Analytical Services for AMRI, where she was responsible for 300 employees at four global sites. One of those sites included SSCI, the cGMP contract research organization founded by Dr. Steve Byrn and Sally Byrn. She has Read more
